testosterone propionate has been researched along with nilutamide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Annoot, D; Clément-Lacroix, P; Deprez, P; Duval, E; Fleury, D; Guédin, D; Hebbe, S; Lefrançois, JM; Lemoullec, JM; Michoux, L; Minet, D; Mollat, P; Nique, F; Peixoto, C; Prangé, T; Robin-Jagerschmidt, C; Thauvin, M; Triballeau, N | 1 |
Chauhan, G; Gupta, S; Mehta, A | 1 |
4 other study(ies) available for testosterone propionate and nilutamide
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Discovery of diarylhydantoins as new selective androgen receptor modulators.
Topics: Anabolic Agents; Androgen Receptor Antagonists; Androgens; Animals; Binding, Competitive; Bone and Bones; Crystallography, X-Ray; Drug Partial Agonism; HeLa Cells; Humans; Hydantoins; Male; Models, Molecular; Muscle, Skeletal; Orchiectomy; Prostate; Rats; Receptors, Androgen; Stereoisomerism; Structure-Activity Relationship; Transcriptional Activation | 2012 |
Stromal-AR influences the growth of epithelial cells in the development of benign prostate hyperplasia.
Topics: Androgen Antagonists; Cell Proliferation; Cells, Cultured; Culture Media, Conditioned; Epithelial Cells; Humans; Imidazolidines; Male; Prostatic Hyperplasia; Receptors, Androgen; Signal Transduction; Stem Cells; Stromal Cells; Testosterone Propionate | 2020 |